Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach-Reference-Cited by-同舟云学术

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach

Author:

Giudici F.¹,Bertisch B.¹²,Negro F.³,Stirnimann G.⁴,Müllhaupt B.⁵,Moradpour D.⁶,Cerny A.⁷,Keiser O.¹,

Affiliation:

1. Institute of Social and Preventive Medicine; Bern Switzerland

2. Checkpoint Zürich; Zürich Switzerland

3. Divisions of Gastroenterology and Hepatology and of Clinical Pathology; University Hospitals; Geneva Switzerland

4. University Clinic of Visceral Surgery and Medicine, Inselspital; Bern Switzerland

5. Swiss Hepato-Pancreato-Biliary Center and Department of Gastroenterology and Hepatology; University Hospital; Zürich Switzerland

6. Division of Gastroenterology and Hepatology; University Hospital; Lausanne Switzerland

7. Epatocentro Ticino Foundation; Lugano Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Swiss Hepatitis C Cohort Study Foundation

AbbVie

Gilead Sciences

Bristol Myers Squibb

Janssen-Cilag

Meso Scale Diagnostics

Novartis

Roche Pharma Switzerland

Roche Diagnostics

PROSPER Fellowship

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

Reference33 articles.

2. Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection;Fretz;Swiss Med Wkly,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献